Erythromycin-induced CXCR4 expression on microvascular endothelial cells.

Area of Science:

• Cell Biology
• Pharmacology
• Immunology

Background:

• Stromal-derived factor-1 (SDF-1) and its receptor CXCR4 are crucial for endothelial cell migration in neovascularization.
• Endothelial CXCR4 expression is tightly regulated, and its role in tissue repair is under investigation.
• Erythromycin (EM), a macrolide antibiotic, exhibits anti-inflammatory properties, but its effects on endothelial cells, particularly CXCR4 expression, are not well understood.

Purpose of the Study:

• To investigate the effect of erythromycin (EM) on the expression of CXCR4 on endothelial cells.
• To determine if EM-induced CXCR4 expression influences endothelial cell migration.
• To explore the potential mechanism underlying EM's anti-inflammatory activity.

Main Methods:

• In vitro studies using microvascular endothelial cells and in vivo studies using lung capillary endothelial cells.
• Treatment with erythromycin (EM) and other antibiotics (including a 16-membered macrolide, josamycin).
• Assessment of CXCR4 surface expression via flow cytometry and functional analysis using chemotaxis assays.

Main Results:

• Erythromycin (EM) significantly induced CXCR4 surface expression on both in vitro and in vivo endothelial cells.
• This induction of CXCR4 expression was specific to 14-membered ring macrolides, not observed with other antibiotics like josamycin.
• EM-induced CXCR4 expression on endothelial cells enhanced their migratory capacity in chemotaxis assays.

Conclusions:

• Erythromycin (EM) upregulates functional CXCR4 expression on endothelial cells.
• This EM-induced CXCR4 expression may facilitate endothelial cell migration to sites of tissue injury.
• The findings suggest a novel mechanism for the anti-inflammatory and tissue-repairing effects of erythromycin.